Elisa Agostinetto

24PUBLICATIONS
115CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsPredictive and prognostic markersClinical midwifery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jun 25, 2026
Neoadjuvant stereotactic body radiation therapy with durvalumab and oleclumab in ER+HER2- breast cancer: a randomized phase 2 trial.

|Dec 22, 2025
Molecular and Clinical Analyses of Gene Fusions Identify Therapeutic Targets in Paired Primary and Metastatic Breast Cancer from the AURORA Program (BIG 14-01).

Chiara Biagioni, Danai Fimereli, Alexandre Irrthum

|Nov 26, 2025
Palbociclib and endocrine therapy diminish adaptive anti-tumor immunity in early breast cancer: The NeoRHEA phase 2 study.

Andreas Papagiannis, Samira Majjaj, Francois P Duhoux

|Feb 24, 2025
Clinical Behavior of Breast Cancer in Young BRCA Carriers and Prediagnostic Awareness of Germline BRCA Status.

Matteo Lambertini, Eva Blondeaux, Loredana M Tomasello

|Nov 12, 2024
Axillary Surgery for Patients With Residual Isolated Tumor Cells (ypN0i+) After Neoadjuvant Systemic Therapy for Early Breast Cancer.

Elisa Agostinetto, Carmela Caballero, Michail Ignatiadis

|May 16, 2024
Characterization of HER2-low breast cancer in young women with germline BRCA1/2 pathogenetic variants: Results of a large international retrospective cohort study.

Francesco Schettini, Eva Blondeaux, Chiara Molinelli

Pageof 4

Frequent Collaborators

8 joint publications

Michail Ignatiadis

7 joint publications

Matteo Lambertini

5 joint publications

Evandro de Azambuja

5 joint publications

Christos Sotiriou